Investor Overview

Investor Overview

Corporate Profile
Reata Pharmaceuticals, Inc. (Nasdaq: RETA) is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing product candidates that modulate the activity of key regulatory proteins involved in the biology of mitochondrial function, oxidative stress, and inflammation to address the unmet medical needs of patients with a variety of serious or life-threatening diseases. Read More >>
RETA (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$18.07
Change (%) Stock is Up 0.04 (0.00%)
Volume13,004
Data as of 08/25/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock chart for: RETA.O.  Currently trading at $18.07 with a 52 week high of $26.90 and a 52 week low of $11.03.
Data provided by Nasdaq. Minimum 15 minutes delayed.


Investor Contact
Lee M. Stern, CFA
The Trout Group
Phone: (646) 378-2922
E-mail: IR@reatapharma.com